FDA Investigator Melissa D Ray
Melissa D Ray has inspections in 5 countries as of 29 Sep 2023. Melissa D Ray has collaborated with a combined 1350 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
5
Last Inspection Date:
29 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
Korea (Republic of),
Italy,
United Kingdom of Great Britain and Northern Ireland,
Switzerland,
United States of America
Co-Investigator(s):
Alan L Truong,
Anita Narula, PhD,
Ann Marie Montemurro,
Arsen Karapetyan,
Binh T Nguyen,
Brandy N Lepage,
Bruce H Mccullough,
Caryn M Mcnab,
Chikako Torigoe, PhD,
Christian D Lynch (CDL),
Dennis Cantellops Paite,
Edwin Melendez,
George Pyramides,
Gloria E Parra,
Ivis Lnegron Torres,
Jacqueline Mdiaz Albertini,
James L Dunnie, Jr,
Jessica L Pressley,
Jose Acruz Gonzalez,
Joseph R Lambert,
Karen E D'orazio,
Kham Phommachanh,
Kumar G Janoria,
Larry K Austin,
Laura Fontan, MS,
Liatte Kreuger, PharmD,
Margaret E Walsh,
Margaret M Annes,
Marlene G Swider,
Maya M Davis,
Michael A Charles,
Michael E Maselli,
Michael R Klapal,
Michael Shanks, MS,
Michelle Y Clark Stuart,
Mihaly S Ligmond,
Mindy M Chou,
Mra M Barbosar,
Mra Munizn,
Nancy L Rolli,
Nicholas A Violand,
Niketa Patel,
Noreen Muniz,
Omotunde O Osunsanmi,
Parul M Patel,
Patricia Fhughes Troost,
Patrick L Wisor,
Philip F Istafanos, DMV, MS,
Prabhu P Raju,
Rebecca E Dombrowski,
Reyes Candau Chacon, PhD,
Samantha J Bradley,
Samina S Khan,
Santos E Camara,
Scott J Lewis,
Scott T Ballard,
Sidney B Priesmeyer,
Steven P Donald,
Susan F Laska, MS,
Terri L Dodds,
Thomas J Arista,
Thuy T Nguyen, LCDR,
Tina M Pawlowski,
Tonia F Bernard,
Torrance J Slayton,
Viviana Matta,
Warren J Lopicka,
Wayne E Seifert,
Xianghong Jing (Emily), PhD,
Zachary A Bogorad,
Zhihao Qiu (Peter), PhD,
Zhong Li, PhD
Melissa D Ray's Documents
Publish Date | Document Type | Title |
---|---|---|
March, 2022 | FDA 483 | Janssen Vaccines Corp. - Form 483, 2022-03-10 |
November, 2015 | FDA 483 | PETNET SOLUTIONS, INC. - Form 483, 2015-11-03 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more